S-1/A: 180 Life Sciences Corp. Seeks $10 Million in Unit Offering to Fuel iGaming Venture

180 Life Sciences Corp. is launching a best efforts offering of up to 7,092,198 units to raise up to $10 million, primarily to fund its new online blockchain casino operations.

Summary

• 180 Life Sciences Corp. has filed an amendment to its Form S-1 registration statement for a proposed offering of up to 7,092,198 units, each consisting of one share of common stock and one and one-half common warrants, or pre-funded units, at an assumed price of $1.41 per unit, aiming to raise up to $10 million.
• The company plans to use the net proceeds for working capital and general corporate purposes, including the development of its recently acquired Gaming Technology Platform.
• The common warrants will have an initial exercise price of $ per share, exercisable immediately and expiring five years from issuance, with a potential reset of the exercise price after 30 days.
• The company is also offering pre-funded units to certain purchasers who would otherwise exceed ownership thresholds, with each pre-funded unit consisting of one pre-funded warrant and the same common warrant.
• The offering is on a best efforts basis with no minimum amount required to be sold, and is expected to be completed by March 11, 2025, unless fully subscribed or terminated earlier.
• Maxim Group LLC is acting as the exclusive placement agent for the offering and will receive a cash commission of 7% of the gross proceeds.
• The company's legacy biotechnology programs are focused on chronic pain, inflammation, and fibrosis, but the company plans to focus the majority of its operations on the creation of the online blockchain casino.
• The company acquired certain source code and intellectual property relating to an online blockchain casino from Elray Resources, Inc. for 1,000,000 shares of Series B Convertible Preferred Stock and warrants to purchase 3,000,000 shares of common stock.
• The company plans to use this technology platform to establish a blockchain-based business aimed at the global iGaming market, focusing initially only on the cryptocurrency market and in the future, potentially the traditional FIAT currency wagering market.
• The company is targeting having the first online casino fully operational and optimized for growth by the end of Q1 2025, although there can be no guarantee that all elements of the commercialization strategy will be completed on this timeline.

Sentiment

Score: 5

Explanation: The document presents a mix of positive and negative aspects. The company is venturing into a high-growth industry with a new technology platform, but faces significant financial challenges and risks. The sentiment is neutral, reflecting the uncertainty of the company's future prospects.

Positives

• The company has acquired a Gaming Technology Platform that incorporates blockchain technology and cryptocurrency operability.
• The company plans to use this technology platform to establish a blockchain-based business aimed at the global iGaming market, focusing initially only on the cryptocurrency market and in the future, potentially the traditional FIAT currency wagering market.
• The company is targeting having the first online casino fully operational and optimized for growth by the end of Q1 2025.
• The company has engaged Maxim Group LLC as the exclusive placement agent for the offering.

Negatives

• The offering is on a best efforts basis with no minimum amount required to be sold.
• The company has a significant accumulated deficit and working capital deficit.
• The company's current cash balance is only expected to be sufficient to fund its planned business operations until approximately December 2025, if it does not raise funding in this offering.
• The company has no operating history in the gaming industry.
• The company will be reliant on third-party gaming content for its games.
• The company will rely on third party cloud services and such providers or services may encounter technical problems and service interruptions.
• The company will face cyber security risks that could result in damage to the company's reputation and/or subject them to fines, payment of damages, lawsuits and restrictions on the company's use of data.

Risks

• The company needs additional financing, both near term and long term, to support its operations.
• The company may not be able to obtain additional financing on terms favorable to it, if at all.
• The company may amend the terms of outstanding common warrants to purchase up to 1,900,138 shares of common stock and/or the December 2024 Warrants to reduce the exercise price of such warrants to equal the exercise price of the common warrants sold in this offering.
• The company's ability to create or purchase a front end for its back end blockchain casino intellectual property assets, commercialize its planned blockchain casino, obtain required licenses and customers, and ultimately generate revenues through such operations is uncertain.
• The company is currently an iGaming/clinical stage biotechnology company that had no revenue for the three or nine months ended September 30, 2024, and for the years ended December 31, 2023 and 2022, and may not generate significant revenue for the near term.
• The company is dependent on the success of its future product candidates, some of which may not receive regulatory approval or be successfully commercialized.
• The company faces risks associated with cryptocurrencies it plans to hold, including legal, commercial, regulatory and technical risks associated therewith; liquidity; reliance on third party service providers; incorrect or fraudulent transactions; limited rights of resource; and lack of banking protections relating thereto.
• The company's accounts payable are significant, and it does not currently have sufficient funds to pay such accounts payable, a large portion of which are past due.
• The company faces intense competition from companies with greater resources and experience than it has.
• The company's ability to receive regulatory approvals for its product candidates, and the timeline and costs associated therewith, including the uncertainties associated with the clinical development and regulatory approval of its drug candidates, including potential delays in the enrollment and completion of clinical trials, issues raised by the U.S. Food and Drug Administration (FDA) and The Medicines and Healthcare products Regulatory Agency (MHRA) is uncertain.
• The company's future product candidates, if approved by regulatory authorities, may be unable to achieve the expected market acceptance and, consequently, limit its ability to generate revenue from new products.
• The majority of the company's license agreements provide the licensors and/or counter-parties the right to use, own and/or exploit such licensed intellectual property.
• The company faces liability from lawsuits (including product liability lawsuits, stockholder lawsuits and regulatory matters), including judgments, damages, fines and penalties and including the outcome of currently pending litigation, potential future government investigations, and other proceedings that may adversely affect its business and results of operations.
• The company's ability to comply with existing and future rules and regulations is uncertain.
• The company's ability to adequately protect its proprietary technology and intellectual property, claims and liability from third parties regarding its alleged infringement of their intellectual property is uncertain.
• The company's information technology systems may fail, including cybersecurity attacks or other data security incidents, that could significantly disrupt the operation of its business.
• The company faces the liquidation preference associated with, dilution caused by the conversion of, and voting rights associated with, its Series B Convertible Preferred Stock.
• The company may acquire other companies which could divert its management's attention, result in additional dilution to its stockholders and otherwise disrupt its operations and harm its operating results and if it makes any acquisitions, they may disrupt or have a negative impact on its business.
• The company is affected by changes in inflation and interest rates, and economic downturns, including potential recessions, as well as macroeconomic, geopolitical, health and industry trends, pandemics, acts of war (including the ongoing Ukraine/Russian and Hamas/Israel conflict) and other large-scale crises, as well as the potential implications of a Congressional impasse over the U.S. debt limit or possible future U.S. governmental shutdowns over budget disagreements.
• The company's ability to maintain its listing of its common stock and public warrants on the Nasdaq Capital Market is uncertain.
• The company relies on suppliers of third-party gaming content and the cost of such content.
• The company's ability to obtain gaming licenses is uncertain.
• The company relies on its management.
• The company's ability to compete in the iGaming market is uncertain.
• The company's ability to compete against existing and new competitors is uncertain.
• The company's ability to manage expenses associated with sales and marketing and necessary general and administrative and technology investments is uncertain.
• General consumer sentiment and economic conditions may affect levels of discretionary customer purchases of the company's products, including potential recessions and global economic slowdowns.

Future Outlook

The company intends to use the net proceeds of this offering for working capital and general corporate purposes, which may include operationalizing and developing its recently acquired Technology Gaming Platform and capital expenditures. Management is targeting having the first online casino fully operational and optimized for growth by the end of Q1 2025.

Industry Context

The global iGaming casino market is experiencing rapid growth, fueled by technological advancements, increased internet penetration, and evolving consumer preferences. The cryptocurrency-based iGaming sector is growing even faster, propelled by the increasing adoption of digital currencies like Bitcoin and Ethereum, which offer more secure, faster, and lower-cost transactions.

Comparison to Industry Standards

• The document mentions Statista estimates the global online gaming sector to reach $97 billion in 2024 and nearly $133 billion by 2029.
• SOFTSWISS estimates growth of over 20% between 2022 and 2023 for crypto-based bets.
• XDA.io estimates the cryptocurrency component of the iGaming industry to have a size of approximately $40 billion, projected to increase to $158 billion by 2028.
• Global Market Insights indicates Europe accounted for over 45% of the global iGaming market share in 2022.
• Statista projects the U.S. iGaming market to reach $39.8 billion by 2029, growing at a CAGR of 9.8%, compared to projected revenue of $25 billion in 2024.
• Grand View Research estimates the global sports betting market will grow at a CAGR of 10-12% from 2023 to 2030, reaching $180 billion in revenue by 2030.
• Market Research Future expects the eSports betting market to grow from $9.9 billion in 2022 to over $30 billion by 2032.

Management Changes

Legal Proceedings

• AmTrust International Underwriters DAC (AmTrust) filed a declaratory relief action against the Company in the U.S. District Court for the Northern District of California seeking a declaration that AmTrust is not obligated to reimburse the Company for fees advanced by the Company to Dr. Marlene Krauss and George Hornig, former officer and directors of the Company, under the directors and officers insurance policy.
• The Company filed its Answer and Counterclaims against AmTrust for bad faith breach of AmTrusts insurance coverage obligations to the Company under the subject insurance policy, seeking at least $2 million in compensatory damages, and punitive damages.
• The Company brought a Third-Party Complaint against its excess insurance carrier, Freedom Specialty Insurance Company (Freedom) seeking declaratory relief that Freedom will also be required to honor its policy coverage as soon as the amount of AmTrusts insurance coverage obligations to the Company has been exhausted.
• A trial on these matters is currently scheduled for May 12, 2025 and the Company and AmTrust are scheduling mediation on February 27, 2025.

Stakeholder Impact

• The offering will dilute the ownership interests of existing stockholders.
• The company's ability to execute its business plans and satisfy current obligations will be impacted by the success of this offering.
• The company's ability to continue as a going concern is dependent on its ability to raise additional capital.

Next Steps

• Complete the technology transfer of the Gaming Technology Platform.
• Develop and enhance a comprehensive business strategy for the iGaming sector.
• Complete a full technology development review of the Gaming Technology Platform.
• Begin front-end development for the online casino.
• Evaluate and select gaming solutions from third-party suppliers.
• Evaluate licensing regimes and secure a reputable and cost-efficient license.
• Develop a marketing plan to identify and attract customers.
• Assemble a growth team of senior management across marketing, technology, compliance, and other areas.
• Establish internal business processes for anti-money laundering, know your customer, accounting, taxation, and responsible gambling tracking.
• Implement business continuity, disaster recovery, and cybersecurity protocols.
• Integrate and test all components of the casino.
• Launch the website to the public and monitor performance, customer engagement, and feedback.

Key Dates

Keywords

iGaming, blockchain casino, offering, units, warrants, cryptocurrency, gaming, ATNF, 180 Life Sciences